Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference9 articles.
1. Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease;Mocci;Journal of Crohns and Colitis,2013
2. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease;Moran;Alimentary Pharmacology & Therapeutics,2013
3. Vedolizumab for induction and maintenance of remission in ulcerative colitis;Bickston;Cochrane Database Systematic Reviews,2014
4. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;The New England Journal of Medicine,2013
5. Efficacy and safety of antiintegrin antibody for inflammatory bowel disease: a systematic review and meta-analysis;Lin;Medicine,2015
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis;Saudi Journal of Gastroenterology;2024-06-07
2. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study;Digestive and Liver Disease;2024-06
3. Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study;Saudi Pharmaceutical Journal;2023-09
4. Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients;Journal of Dermatological Treatment;2022-10-18
5. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study;Journal of Crohn's and Colitis;2022-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3